Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein

Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein

US Patent 10093665 · Granted Oct 9, 2018

Estimated economic value: $15,806,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

TrkA antibody and application thereof2024
Nano complex comprising a nano drug delivery matrix; and a ginseng extract or a 2023
Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole2023
Glycoside derivatives and uses thereof2022
Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-2021
Nano complex comprising a nano drug delivery matrix; and a ginseng extract or a 2021
Pharmaceutical compositions comprising an aromatse inhibitors2018
Glycoside derivatives and uses thereof2018
Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-2017
Solid oral formulations and crystalline forms of an inhibitor of apoptosis prote2017
Solid oral formulations and crystalline forms of an inhibitor of apoptosis prote2017
Solid oral formulations and crystalline forms of an inhibitor of apoptosis prote2017